Site-Specific Modification of Epstein-Barr Virus-Encoded RNA 1 with N2-Benzylguanosine Limits the Binding Sites Occupied by PKR
- 26 February 2004
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 5 (3), 383-386
- https://doi.org/10.1002/cbic.200300816
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PKR; a sentinel kinase for cellular stressOncogene, 1999
- Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old actorProceedings of the National Academy of Sciences, 1999
- Molecular Mechanisms of Interferon Resistance Mediated by Viral-Directed Inhibition of PKR, the Interferon-Induced Protein KinasePharmacology & Therapeutics, 1998
- The eIF‐2α kinases and the control of protein synthesis 1The FASEB Journal, 1996
- The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo.Proceedings of the National Academy of Sciences, 1995
- Proteins that interact with PKRBiochimie, 1994
- Regulation of the interferon-inducible eIF-2α protein kinase by small RNAsBiochimie, 1994
- Comparative analysis of the regulation of the interferoninducible protein kinase PKR by Epstein - Barr virus RNAs EBER-1 and EBER-2 and adenovirus VA, RNANucleic Acids Research, 1993
- Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferonCell, 1990
- Viral latency and transformation: The strategy of Epstein-Barr virusCell, 1989